HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

HS 1030

inhibits DNA replication of simian virus 40; structure in first source

Also Known As:

HS-1030

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Bile Acids and Salts: 11432
      - Cholic Acids: 14
        Deoxycholic Acid: 963
        Ursodeoxycholic Acid: 2822
        HS 1030: 3
    - Cholanes
      - Cholic Acids: 14
        Deoxycholic Acid: 963
        Ursodeoxycholic Acid: 2822
        HS 1030: 3

Experts

1.	Choi, Hye Joung: 1 article (07/2004)
2.	Choi, Yung Hyun: 1 article (07/2004)
3.	Chung, Hae Young: 1 article (07/2004)
4.	Kim, Nam Deuk: 1 article (07/2004)
5.	Park, Sang Eun: 1 article (07/2004)
6.	Suh, Hongsuk: 1 article (07/2004)
7.	Yee, Su Bog: 1 article (07/2004)
8.	Yoo, Young Hyun: 1 article (07/2004)

Related Diseases

1.	Colonic Neoplasms (Colon Cancer) 07/01/2004 - "In the present study, the effects of the synthetic derivatives of ursodeoxycholic acid (UDCA), HS-1030 and HS-1183, and chenodeoxycholic acid (CDCA), HS-1199 and HS-1200, on the proliferation of HT-29 human colon cancer cells were investigated. "
2.	Neoplasms (Cancer) 02/26/1997 - "Based on these results, we speculated that HS-1030 might be a promising candidate as angiogenesis inhibitor for use in the management of diseases accompanied by uncontrolled angiogenesis including solid tumor."
3.	Liver Neoplasms (Liver Cancer) 02/01/1997 - "These results suggest that HS-1030 may be a good candidate as a drug for the treatment of liver cancer."
4.	Hepatocellular Carcinoma (Hepatoma) 02/01/1997 - "The effects of ursodeoxycholic acid (UDCA) and its novel derivative, named as HS-1030, on the proliferation of HepG2, human hepatocellular carcinoma cells were investigated. "

Related Drugs and Biologics

1.	Ursodeoxycholic Acid (Urso)
2.	Chenodeoxycholic Acid (Chenix)
3.	HS-1199
4.	HS 1200
5.	HS 1183
6.	Angiogenesis Inhibitors